CVR number 35476490
Industry 72.1900 Other research and experimental development on natural sciences and engineering

DRUGSTER ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  1.1% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 2.2% 2.2% 2.4% 2.5%  
Credit score (0-100)  0 68 68 65 63  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 0 0 0 0  
Gross profit  0.0 1,509 1,459 819 808  
EBITDA  0.0 393 440 521 796  
EBIT  0.0 393 440 521 796  
Pre-tax profit (PTP)  0.0 0.0 0.0 -18.5 0.0  
Net earnings  0.0 373.0 482.6 -17.4 0.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -18.5 0.0  
 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Tangible assets total  0.0 0.0 70.2 0.0 0.0  
Shareholders equity total  0.0 599 599 582 1,426  
Interest-bearing liabilities  0.0 0.0 440 461 1,539  
Balance sheet total (assets)  0.0 7,912 10,398 13,029 16,242  
Net Debt  0.0 -1.6 76.4 461 1,450  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,509 1,459 819 808  
Gross profit growth  0.0% 0.0% -3.3% -43.9% -1.3%  
Employees  0 3 2 0 1  
Employee growth %  0.0% 0.0% -33.3% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 7,912 10,398 13,029 16,242  
Balance sheet change%  0.0% 0.0% 31.4% 25.3% 24.7%  
Added value  0.0 392.8 439.6 521.4 796.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 7,052 2,269 1,239 1,120  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 26.0% 30.1% 63.7% 98.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 5.0% 4.8% 4.8% 5.6%  
ROI %  0.0% 5.6% 5.6% 5.8% 6.9%  
ROE %  0.0% 62.2% 80.5% -2.9% 0.0%  

Solidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 7.6% 5.8% 4.5% 8.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -0.4% 17.4% 88.3% 182.1%  
Gearing %  0.0% 0.0% 73.5% 79.1% 107.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 200.3% 127.7% 81.8%  

Liquidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Quick Ratio  0.0 0.9 0.5 0.8 1.3  
Current Ratio  0.0 0.9 0.5 0.8 1.3  
Cash and cash equivalent  0.0 1.6 364.0 0.0 88.7  

Capital use efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -69.9 -1,047.6 -754.5 1,124.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 131 220 0 796  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 131 220 0 796  
EBIT / employee  0 131 220 0 796  
Net earnings / employee  0 124 241 0 0